Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 02-2025 | 02-2024 | 02-2023 | |
| Sales | 118 | 123 | 170 |
| Operating Expenses | 334 | 890 | 1,366 |
| Operating Income | -216 | -767 | -1,196 |
| Interest Expense | 0 | 91 | 74 |
| Other Income | 0 | -548 | -1,817 |
| Pre-tax Income | -216 | -1,406 | -3,087 |
| Income Tax | 0 | -9 | -9 |
| Net Income Continuous | -216 | -1,398 | -3,078 |
| Net Income | $-216 | $-1,398 | $-3,078 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.04 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.04 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.04 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.04 |
| EBITDA(a) | $-216 | $-1,295 | $-2,969 |